This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
Rosuvastatin markedly improved atherogenic dyslipidemia of Metabolic syndrome
This page is a summary of: Effect of rosuvastatin on dyslipidemia and other parameters associated with metabolic syndrome in Saudi patients, Nigerian Journal of Clinical Practice, January 2016, Medknow,
DOI: 10.4103/1119-3077.197021.
You can read the full text:
The following have contributed to this page
Journal of Eating Disorders
How does life satisfaction compare for individuals with eating disorders? This study looked at the connection of life satisfaction with eating disorder symptom severity as well as family history ...
Steroids
Microorganisms are capable of converting a whole range of organic compounds into their modified derivatives. Microorganisms such as Fungi, bacteria, and yeast have been utilized successfully as in ...
Behavioral Neuroscience
Ketamine is a medical drug often used for anesthesia, but it has recently attracted interest for its potential to treat mood disorders, such as depression and post-traumatic stress disorder (PTSD)....
